Artificial intelligence continues to transform biotechnology with several new innovations: Harvard Medical School researchers have developed an AI tool for real-time distinction between glioblastoma and similar tumors during surgery. Separately, protein language models are becoming more interpretable, revealing key protein family and function data. In diagnostics, a new AI-based stool test achieves 90% accuracy in early colorectal cancer detection, signaling a non-invasive screening breakthrough.